Author

Svetlana Soroka

Observed names: S. M. Soroka, С. М. Сорока

Institution: Leningrad Regional Cancer Center

Observed institution: Leningrad Regional Cancer Center

ORCID: 0009-0001-4758-0757

Observed ORCID: 0009-0001-4758-0757

OpenAlex ID: A5035544902

Defendor: Real-world evidence of primary prolonged G-CSF prophylaxis by empegfilgrastim for relative dose intensity compliance in patients with solid tumors—The primary analysis.

2022 · Anton Snegovoy, Alexander Dergunov, et al. · Journal of Clinical Oncology · 3

Efficacy and safety of lenvatinib and pembrolizumab in the treatment of endometrial cancer: data from routine clinical practice in Russia

2023 · A. A. Rumyantsev, A. E. Protasova, et al. · Tumors of female reproductive system · 2

Incidence of severe and febrile neutropenia in cancer patients treated with myelosuppressive chemotherapy in real clinical oncology practice: Preliminary results from the FLAME study.

2022 · Anton Snegovoy, Inessa Kononenko, et al. · Journal of Clinical Oncology · 1

The long-term clinical efficacy and safety of lenvatinib plus pembrolizumab in endometrial cancer: data from routine clinical practice in Russia

2024 · A. E. Protasova, A. A. Rumyantsev, et al. · Tumors of female reproductive system

Works count: 5

Citation count: 6

H-index: 2

I10-index: